Clinical Trial Update: Danish Multicenter Study of Adalimumab in Spondyloarthritis [Phase 4]

View source ↗

Summary

A Danish multicenter Phase 4 trial evaluates adalimumab for spondyloarthritis, with the study status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spondyloarthritis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: Glostrup University Hospital, Copenhagen | Conditions: Spondyloarthritis | Phase 4 | Status: UNKNOWN